REPRIEVE

February 13, 2017

How to Make Preventing Heart Disease in HIV Fun and Exciting: The REPRIEVE Trial

The people researching cardiovascular disease in HIV have quite the challenge.Because when you think about it for a second, we HIV treaters are a pretty spoiled bunch […]
February 13, 2017

Campaign Launched to Get More Women Into HIV Heart Health Study

People with HIV seldom die of AIDS-related opportunistic infections anymore. Thanks to modern medicine called highly active antiretroviral therapy, or HAART, many people diagnosed with HIV […]
February 9, 2017

Can Statins Cut Heart Disease Risk in HIV Patients?

February is American Heart Month, and traditionally a time when organizations such as the American Heart Association ramp up initiatives to promote awareness of heart disease. […]
February 2, 2017

Should People With HIV Take a Statin?

HIV is linked to a higher heart disease risk. Research suggests statins can help. But definitive proof likely won’t come for another three years. Even when […]
December 29, 2016

Walk Your Way to a Healthier Heart

Did you know that walking can lower your risk of heart-related conditions as much as running? A study funded by the National Heart, Lung, and Blood […]
December 1, 2016

The REPRIEVE Trial: The Last Word on Cardiovascular Disease in HIV-positive Persons (Hopefully)

Your 50 Year-old, female, HIV-positive patient, presents for a follow-up visit. She has heard that the risk of cardiovascular disease is increased among people living with […]
December 1, 2016

NIH Statement on World AIDS Day

This year, the world marked the 35th anniversary of the first published reports of what would come to be known as HIV/AIDS. This disease has wrought […]
November 23, 2016

Stopping a silent killer

“I had no idea that since I have HIV, I may be twice as likely to have a heart event compared to the general population,” said Frank […]
September 29, 2016

Woman-Centric Research and Why it’s Time to Listen to the Ladies

Earlier this month, AVAC hosted a webinar to explain and explore the complex issues of hormonal contraceptives and HIV risk in light of a new analysis that is generating […]